Kidney Transplant Overview

Principles

Definition

Kidney transplant is a significant area of clinical and translational research focused on the surgical procedure involving the transfer of a healthy kidney from a donor into a patient with end-stage renal disease. This academic concept encompasses the study of donor and recipient evaluation, surgical techniques, immunosuppressive therapy, management of complications, long-term outcomes, and the ethical and socioeconomic implications of organ transplantation.

Ontological type

Immunosuppressive Regimens

Donor Selection

Recipient Evaluation

Key developments

Key Figures

Establishment of Immunosuppression era

Paul I. Terasaki [1] was a pioneering figure at Harvard University [3] and the University of California, San Francisco [4] during the Establishment of Immunosuppression era. His key contribution during this era was the Significance of the Positive Crossmatch Test in Kidney Transplantation [5], which defined crossmatch positivity as a risk stratification tool and helped explain improvements in early graft outcomes. Robert I. Lechler [2] contributed to the immunology of kidney transplantation, notably in the 1982 study Restoration of immunogenicity to passenger cell-depleted kidney allografts by the addition of donor strain dendritic cells [6]. Together, Terasaki's crossmatch emphasis and Lechler's dendritic-cell work helped advance risk stratification and understanding of cellular mechanisms that underpinned the immunosuppressive strategies that defined this era.

Diagnostic Standardization and Personalization era

Philip F. Halloran [1] is a leading figure in transplant nephrology who collaborated with Harvard University [3] and Stanford University [4] during the Diagnostic Standardization and Personalization era. His key contributions in this era include the International standardization of criteria for the histologic diagnosis of renal allograft rejection—the Banff working classification of kidney transplant pathology [7] and its 2008 update, Banff 07 [6], which together established cross-center comparability and objective thresholds enabling biomarker-guided personalization. Robert B. Colvin [2] is another prominent figure who was affiliated with Harvard University [3] and Johns Hopkins University [5] in this era. Colvin co-authored the Banff 07 update [6] and the Banff 1993 paper [7], reinforcing standardized criteria that supported diagnostic consistency and informed strategies to balance graft function with minimized drug toxicity in personalization efforts.

Data-Driven Policy and Preservation era

In the Data-Driven Policy and Preservation era for kidney transplantation, representative authors include Dorry Segev, Lentine KL, and Kasiske, whose work anchored policy-relevant insights in national registries and multicenter cohorts. Segev used registry data to model waitlist dynamics, evaluate allocation reforms, and quantify the economic implications of expanding the donor pool. Kasiske, through SRTR analytics, provided benchmarks on waitlist mortality, graft survival, and donor-recipient matching that informed allocation metrics and resource prioritization. Lentine's investigations into disparities, access to transplantation, and post-transplant outcomes complemented policy science by guiding surveillance and equity safeguards.